Ceritinib + Trametinib in Patients With Advanced ALK-Positive Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT03087448 · TERMINATED
Trial details
- NCT number
- NCT03087448
- Sponsor
- University of California, San Francisco
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-09
- Primary completion
- 2022-04-30
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.